Rebecca A. Dent (Singapore, Singapore)
NCCS - National Cancer Centre SingaporeAuthor Of 4 Presentations
Proffered Paper session 1 (ID 12)
Invited Discussant LBA3 and 162O (ID 305)
Lecture Time
14:15 - 14:25
Session Name
Room
Munich Hall
Date
Tue, 03.05.2022
Time
13:45 - 15:15
AstraZeneca - Controversies in Breast Cancer (ID 48)
Treatment beyond CDK4/6i - what comes next? (ID 471)
Lecture Time
12:00 - 12:15
Session Name
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
Emerging new drugs and strategies for breast cancer (ID 25)
Targeting the PIK/AKT/mTOR pathway: Making sense of the relationships (ID 404)
Lecture Time
09:05 - 09:25
Room
Frankfurt Hall
Date
Thu, 05.05.2022
Time
08:45 - 10:15
José Baselga: Cancer’s fiercest opponent (ID 49)
Panel discussion (ID 477)
Lecture Time
11:05 - 11:20
Authors
Session Name
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
Presenter Of 3 Presentations
Emerging new drugs and strategies for breast cancer (ID 25)
Targeting the PIK/AKT/mTOR pathway: Making sense of the relationships (ID 404)
Lecture Time
09:05 - 09:25
Room
Frankfurt Hall
Date
Thu, 05.05.2022
Time
08:45 - 10:15
Proffered Paper session 1 (ID 12)
Invited Discussant LBA3 and 162O (ID 305)
Lecture Time
14:15 - 14:25
Session Name
Room
Munich Hall
Date
Tue, 03.05.2022
Time
13:45 - 15:15
AstraZeneca - Controversies in Breast Cancer (ID 48)
Treatment beyond CDK4/6i - what comes next? (ID 471)
Lecture Time
12:00 - 12:15
Session Name
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
Moderator Of 1 Session
Frankfurt Hall
Special Symposium
Date
Thu, 05.05.2022
Time
08:45 - 10:15
Room
Frankfurt Hall
Session Type
Special Symposium